CVRx, Inc. Common Stock (CVRX) Stock Price

CVRXStock

$3.37−59.62%52W

Market Cap$89.78M

P/E—

PEG Ratio—

Div yield—

Beta0.71

CVRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-46.30%

Price vs S&P 500 (4W)-39.42%

VGM Score58.52

Book Value / Share (Quarterly)$1.10

P/TBV (Annual)3.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)36.10%

Cash Flow / Share (Quarterly)$-1.52

Price vs S&P 500 (YTD)-67.59%

Gross Margin (TTM)86.18%

Net Profit Margin (TTM)-89.15%

EPS (TTM)$-2.01

10-Day Avg Trading Volume1.25M

EPS Excl Extra (TTM)$-2.01

Revenue Growth (5Y)56.42%

EPS (Annual)$-2.04

ROI (Annual)-60.00%

Gross Margin (Annual)85.33%

Net Profit Margin (5Y Avg)-166.12%

Cash / Share (Quarterly)$2.74

Revenue Growth QoQ (YoY)19.61%

ROA (Last FY)-50.87%

Revenue Growth TTM (YoY)11.73%

EBITD / Share (TTM)$-1.88

ROE (5Y Avg)-68.33%

Operating Margin (TTM)-84.62%

Cash Flow / Share (Annual)$-1.55

P/B Ratio2.69x

P/B Ratio (Quarterly)8.55x

Net Income / Employee (Annual)$-239,000

EV / Revenue (TTM)1.09x

Net Interest Coverage (TTM)-8.15x

ROA (TTM)-48.38%

EPS Incl Extra (Annual)$-2.04

Current Ratio (Annual)7.63x

Quick Ratio (Quarterly)8.58x

3-Month Avg Trading Volume0.60M

52-Week Price Return-59.62%

Revenue / Employee (TTM)$264,900

Tangible BV / Share (Quarterly)$3.98

P/S Ratio (Annual)1.38x

Asset Turnover (Annual)0.54x

52-Week High$11.30

Operating Margin (5Y Avg)-137.77%

EPS Excl Extra (Annual)$-2.04

CapEx CAGR (5Y)13.35%

26-Week Price Return-35.05%

Quick Ratio (Annual)6.49x

13-Week Price Return-48.11%

Total Debt / Equity (Annual)1.26x

Current Ratio (Quarterly)10.20x

Enterprise Value$64.51M

Revenue / Share Growth (5Y)47.26%

Asset Turnover (TTM)0.54x

Revenue / Employee (Annual)$254,000

Inventory Turnover (Annual)0.68x

Pretax Margin (Annual)-94.13%

Cash / Share (Annual)$2.88

3-Month Return Std Dev142.35%

Gross Margin (5Y Avg)80.60%

Net Income / Employee (TTM)$-236,100

ROE (Last FY)-135.56%

Net Interest Coverage (Annual)-7.90x

EPS Basic Excl Extra (Annual)$-2.04

Receivables Turnover (TTM)6.52x

Total Debt / Equity (Quarterly)2.01x

EPS Incl Extra (TTM)$-2.01

Receivables Turnover (Annual)5.68x

ROI (TTM)-55.25%

P/S Ratio (TTM)1.33x

Pretax Margin (5Y Avg)-165.79%

Revenue / Share (Annual)$2.17

Tangible BV / Share (Annual)$5.29

Price vs S&P 500 (52W)-77.93%

Year-to-Date Return-55.63%

5-Day Price Return14.55%

EPS Normalized (Annual)$-2.04

ROA (5Y Avg)-38.60%

Net Profit Margin (Annual)-94.10%

Month-to-Date Return-39.13%

Cash Flow / Share (TTM)$-2.03

EBITD / Share (Annual)$-1.94

Operating Margin (Annual)-90.49%

LT Debt / Equity (Annual)1.26x

ROI (5Y Avg)-42.85%

LT Debt / Equity (Quarterly)2.01x

EPS Basic Excl Extra (TTM)$-2.01

P/TBV (Quarterly)5.03x

P/B Ratio (Annual)4.73x

Inventory Turnover (TTM)0.68x

Pretax Margin (TTM)-89.17%

Book Value / Share (Annual)$1.49

Price vs S&P 500 (13W)-50.90%

Beta0.71x

Revenue / Share (TTM)$2.24

ROE (TTM)-120.77%

52-Week Low$2.20

vGradeB

gGradeB

mGradeD

vgmGradeC

CVRX Earnings Surprise History

Q2 25-0.57est. -0.52

Q3 25-0.49est. -0.50

Q4 25-0.46est. -0.44

Q1 26-0.50est. -0.50

Q2 26-0.53est. -0.52

CVRX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
CVRXCVRx, Inc. Common Stock	B	B	D	$3.37
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About CVRx, Inc. Common Stock

CVRx Inc is a commercial-stage medical device company developing minimally invasive neuromodulation solutions for heart failure and other cardiovascular diseases. Its proprietary Barostim platform uses Baroreflex Activation Therapy to restore autonomic nervous system balance and improve cardiac function. The company generates revenue primarily from the U.S. market.